Jupiter Neurosciences
JUNS----
Jupiter Neurosciences climbs 5% on $100M ALA-002 licensing deal
US Stock Market Update·Jupiter Neurosciences jumps 4% on $100M drug licensing deal
US Stock Market Update·Jupiter Neurosciences surges 39% on $100M deal for ALA-002 rights
US Stock Market Update·